Question 1

What is the catalog number for Progesterone Receptor, phosphorylated (Ser190) (Nuclear Receptor Subfamily 3 Group C Member 3, PR, NR3C3, PGR) discontinued?

Accepted Answer

The catalog number for Progesterone Receptor, phosphorylated (Ser190) (Nuclear Receptor Subfamily 3 Group C Member 3, PR, NR3C3, PGR) discontinued is P9007-01F.

Question 2

What sizes are available for Progesterone Receptor, phosphorylated (Ser190) (Nuclear Receptor Subfamily 3 Group C Member 3, PR, NR3C3, PGR) discontinued?

Accepted Answer

Progesterone Receptor, phosphorylated (Ser190) (Nuclear Receptor Subfamily 3 Group C Member 3, PR, NR3C3, PGR) discontinued is available in the following size(s): 50 µg.

Question 3

Is Progesterone Receptor, phosphorylated (Ser190) (Nuclear Receptor Subfamily 3 Group C Member 3, PR, NR3C3, PGR) discontinued in stock?

Accepted Answer

Progesterone Receptor, phosphorylated (Ser190) (Nuclear Receptor Subfamily 3 Group C Member 3, PR, NR3C3, PGR) discontinued

Selected Variant

P9007-01F

Size: 50 µg

Product Specifications

Clonality

Pab

Question 4

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Question 5

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.